<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<title>S1322</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Albertus Extra Bold";
	panose-1:2 14 8 2 4 3 4 2 2 4;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:Times;
	panose-1:2 2 6 3 6 4 5 2 3 4;}
@font-face
	{font-family:Albertus;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	background:navy;
	font-size:12.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
p.FronterPage, li.FronterPage, div.FronterPage
	{mso-style-name:FronterPage;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Para10pt
	{mso-style-name:Para10pt;
	font-family:"Times New Roman",serif;}
p.PrefileFronterTitle, li.PrefileFronterTitle, div.PrefileFronterTitle
	{mso-style-name:PrefileFronterTitle;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.StylePrefileFronterTitleLeft, li.StylePrefileFronterTitleLeft, div.StylePrefileFronterTitleLeft
	{mso-style-name:"Style PrefileFronterTitle + Left";
	margin-top:0in;
	margin-right:-.2in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BillHead
	{mso-style-name:BillHead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeading2
	{mso-style-name:BillHeading2;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillLanguage
	{mso-style-name:BillLanguage;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.HangingAnAct, li.HangingAnAct, div.HangingAnAct
	{mso-style-name:HangingAnAct;
	mso-style-link:"HangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.HangingAnActChar
	{mso-style-name:"HangingAnAct Char";
	mso-style-link:HangingAnAct;
	letter-spacing:.2pt;}
span.11ptChar
	{mso-style-name:11ptChar;
	font-family:"Times New Roman",serif;}
span.BillHeadUnBold
	{mso-style-name:BillHeadUnBold;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.bpuBill, li.bpuBill, div.bpuBill
	{mso-style-name:bpuBill;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:26.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuHeadSpon, li.bpuHeadSpon, div.bpuHeadSpon
	{mso-style-name:bpuHeadSpon;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.bpuHeadSponChar
	{mso-style-name:bpuHeadSponChar;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuIntro, li.bpuIntro, div.bpuIntro
	{mso-style-name:bpuIntro;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuLegislature, li.bpuLegislature, div.bpuLegislature
	{mso-style-name:bpuLegislature;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuNormText, li.bpuNormText, div.bpuNormText
	{mso-style-name:bpuNormText;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuReprint, li.bpuReprint, div.bpuReprint
	{mso-style-name:bpuReprint;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuSponsor, li.bpuSponsor, div.bpuSponsor
	{mso-style-name:bpuSponsor;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuState, li.bpuState, div.bpuState
	{mso-style-name:bpuState;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:32.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
span.charMarlett
	{mso-style-name:charMarlett;
	font-family:Marlett;}
p.ElevenPt, li.ElevenPt, div.ElevenPt
	{mso-style-name:ElevenPt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage12pt, li.FronterPage12pt, div.FronterPage12pt
	{mso-style-name:FronterPage12pt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageBillHeading, li.FronterPageBillHeading, div.FronterPageBillHeading
	{mso-style-name:FronterPageBillHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FronterPageNOCAPS, li.FronterPageNOCAPS, div.FronterPageNOCAPS
	{mso-style-name:FronterPageNOCAPS;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times",serif;}
p.FronterPageTBox2, li.FronterPageTBox2, div.FronterPageTBox2
	{mso-style-name:FronterPageTBox2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageTextBox, li.FronterPageTextBox, div.FronterPageTextBox
	{mso-style-name:FronterPageTextBox;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.FronterSameAs, li.FronterSameAs, div.FronterSameAs
	{mso-style-name:FronterSameAs;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Pg2Footer, li.Pg2Footer, div.Pg2Footer
	{mso-style-name:Pg2Footer;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.Style10pt
	{mso-style-name:"Style 10 pt";
	font-family:"Times New Roman",serif;}
p.StyleFronterPage11pt, li.StyleFronterPage11pt, div.StyleFronterPage11pt
	{mso-style-name:"Style FronterPage + 11 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.StyleFronterPageLoweredby3pt, li.StyleFronterPageLoweredby3pt, div.StyleFronterPageLoweredby3pt
	{mso-style-name:"Style FronterPage + Lowered by  3 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	position:relative;
	top:3.0pt;}
p.StyleFronterSameAsPatternSolid100White, li.StyleFronterSameAsPatternSolid100White, div.StyleFronterSameAsPatternSolid100White
	{mso-style-name:"Style FronterSameAs + Pattern\: Solid \(100%\) \(White\)";
	margin:0in;
	margin-bottom:.0001pt;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Whereas
	{mso-style-name:Whereas;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
p.bpuWpGraphic, li.bpuWpGraphic, div.bpuWpGraphic
	{mso-style-name:bpuWpGraphic;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.LeftBrackt
	{mso-style-name:LeftBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.RightBrackt
	{mso-style-name:RightBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.Superscript
	{mso-style-name:Superscript;
	font-family:"Albertus",sans-serif;
	font-weight:bold;
	vertical-align:super;}
p.sponUdate, li.sponUdate, div.sponUdate
	{mso-style-name:sponUdate;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.BoldItal
	{mso-style-name:BoldItal;
	font-weight:bold;
	font-style:italic;}
p.amendfooter, li.amendfooter, div.amendfooter
	{mso-style-name:amendfooter;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.HangingSup, li.HangingSup, div.HangingSup
	{mso-style-name:HangingSup;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableBottom, li.HangingTableBottom, div.HangingTableBottom
	{mso-style-name:HangingTableBottom;
	margin-top:0in;
	margin-right:1.0in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableTop, li.HangingTableTop, div.HangingTableTop
	{mso-style-name:HangingTableTop;
	margin-top:0in;
	margin-right:.5in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 14.0in;
	margin:1.5in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 14.0in;
	margin:1.5in 113.75pt 1.0in 113.75pt;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 14.0in;
	margin:1.0in 1.75in 1.2in 2.0in;}
div.WordSection3
	{page:WordSection3;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=bpuBill><a name=bpuFrontPg></a>SENATE, No. 1322 </p>

<p class=bpuWpGraphic></p>

<p class=bpuState>STATE OF NEW JERSEY</p>

<p class=bpuLegislature>221st LEGISLATURE</p>

<p class=bpuWpGraphic>  </p>

<p class=bpuIntro>PRE-FILED FOR INTRODUCTION IN THE 2024 SESSION</p>

<p class=bpuIntro>&nbsp;</p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:auto'>
</span>

<div class=WordSection2>

<p class=bpuIntro>&nbsp;</p>

<p class=bpuSponsor>Sponsored by:</p>

<p class=bpuSponsor>Senator  NELLIE POU</p>

<p class=bpuSponsor>District 35 (Bergen and Passaic)</p>

<p class=bpuSponsor>Senator  M. TERESA RUIZ</p>

<p class=bpuSponsor>District 29 (Essex and Hudson)</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>SYNOPSIS</p>

<p class=bpuNormText>     Provides for expansion of certain support team
addiction recovery programs; appropriates $1,995,000 from opioid recovery and remediation
fund.</p>

<p class=bpuNormText>&nbsp;</p>

<p class=bpuSponsor>CURRENT VERSION OF TEXT </p>

<p class=bpuNormText>     Introduced Pending Technical Review by Legislative
Counsel.</p>

<p class=bpuNormText>   </p>

</div>

<span style='font-size:10.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<p class=HangingAnAct style='line-height:150%'><span class=BillHead>An Act</span><span
class=HangingAnActChar> </span>concerning support team addiction recovery
programs, amending P.L.2023, c.25, supplementing Chapter 2G of Title 26 of the
Revised Statutes, and making an appropriation.</p>

<p class=HangingAnAct style='margin-left:0in;text-indent:0in;line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     <span class=BillHeading2>Be It
Enacted </span><span class=BillLanguage>by the Senate and General Assembly of
the State of New Jersey:</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     1.  Section 1 of P.L.2023,
c.25 (C.26:2G-39) is to read as follows:</p>

<p class=MsoNormal style='line-height:150%'>     1. a. There is created in the
Department of the Treasury a dedicated, non-lapsing fund to be known as the
Opioid Recovery and Remediation Fund.</p>

<p class=MsoNormal style='line-height:150%'>     b.    To the extent consistent
with the terms of a national opioid litigation resolution subject to this act,
the State Treasurer shall deposit into the fund the State's share of moneys
received as a result of such resolution.  Any interest and other income earned
on moneys in the fund, and any other moneys that may be appropriated or
otherwise become available for purposes of the fund, shall be credited to and deposited
in the fund.  For the purposes of this section, moneys paid to counties or
municipalities shall not be considered to be part of the State's share of
moneys received as a result of a national opioid litigation resolution.  Any
moneys received by any State department pursuant to a national opioid
litigation settlement subject to this act shall be transferred into the fund.</p>

<p class=MsoNormal style='line-height:150%'>     c. (1) Moneys in the fund are
hereby appropriated, shall be subject to the applicable requirements of the
relevant national opioid litigation resolution and any applicable agreement
entered into pursuant to section 3 of P.L.2023, c.25 (C.26:2G-41), and shall be
dedicated and used only for:</p>

<p class=MsoNormal style='line-height:150%'>     (a) the purposes described in
subsection e. of this section; and</p>

<p class=MsoNormal style='line-height:150%'>     (b) the payment of attorneys'
fees, costs, and related litigation expenses related to the national opioid
litigation resolution.</p>

<p class=MsoNormal style='line-height:150%'>     (2) The Department of Human
Services shall be designated the lead agency for the State for purposes of
directing the disbursement and allocation of the State's share of any moneys
that are allocated to or otherwise received by the State as a result of a
national opioid litigation resolution and for monitoring the use of moneys
disbursed to counties or municipalities under a national opioid litigation resolution
or under an agreement entered into pursuant to section 3 of P.L.2023, c.25
(C.26:2G-41), to the extent required by such agreements, and, in coordination
with the State Comptroller and the Attorney General, ensuring that the use of
such moneys complies with the purposes set forth in this act and is consistent
with the terms of the applicable national opioid litigation resolution and any
applicable agreement entered into pursuant to section 3 of P.L.2023, c.25
(C.26:2G-41).</p>

<p class=MsoNormal style='line-height:150%'>     (a) The department shall have
primary responsibility for ensuring that the various reporting, compliance, and
administrative functions imposed upon the State pursuant to the terms and
conditions of any national opioid litigation resolution and any applicable
agreement entered into pursuant to section 3 of P.L.2023, c.25 (C.26:2G-41) are
performed, and shall serve as the single point of contact for the State for
settlement fund administrators and trustees to submit requests for disbursement
of settlement funds.</p>

<p class=MsoNormal style='line-height:150%'>     (b) The department shall be
authorized to make determinations regarding disbursement and allocation of the
State's share of such proceeds in accordance with the requirements or terms of
any national opioid litigation resolution and any applicable agreement entered
into pursuant to section 3 of P.L.2023, c.25 (C.26:2G-41), which may include
designations of regions for the allocation of the State's share of such
proceeds, in addition to taking such other actions as may be assigned or
required to be performed by the lead agency or single point of contact for the
State under the terms of any national opioid litigation resolution and any
applicable agreement entered into pursuant to section 3 of P.L.2023, c.25
(C.26:2G-41).</p>

<p class=MsoNormal style='line-height:150%'>     (c) The department shall
receive and review reports from each county regarding the expenditure of any
moneys received by the county as a result of a national opioid litigation
resolution.</p>

<p class=MsoNormal style='line-height:150%'>     (d) (i) The department shall
be authorized to adopt, amend, or repeal regulations as necessary to carry out
the intent and provisions of P.L.2023, c.25 (C.26:2G-39 et seq.).</p>

<p class=MsoNormal style='line-height:150%'>     (ii) Notwithstanding the
provisions of the &quot;Administrative Procedure Act,&quot; P.L.1968, c.410
(C.52:14B-1 et seq.), to the contrary, the department may, immediately upon
filing proper notice with the Office of Administrative Law, adopt rules and
regulations as shall be necessary to enable it to carry out the department's
duties, functions, and powers with respect to this act.  Rules and regulations
adopted pursuant to this <b><span style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>subsubparagraph<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>sub-subparagraph</u>
shall be effective immediately upon filing with the Office of Administrative
Law and shall be in effect for a period not to exceed 18 months, and shall,
thereafter, be amended, adopted, or readopted by the department in accordance
with the provisions of the &quot;Administrative Procedure Act,&quot; P.L.1968,
c.410 (C.52:14B-1 et seq.).</p>

<p class=MsoNormal style='line-height:150%'>     (3) Notwithstanding any other
law or regulation to the contrary, there is hereby appropriated: (a) moneys
from the fund to the Department of Human Services, which shall allocate the
appropriated funds in accordance with the provisions of subsections d., e., and
f. of this section; and (b) to the extent applicable, moneys paid to the State
as a result of a national opioid litigation resolution that have been allocated
to a county or municipality in accordance with the terms of the national opioid
litigation resolution or a related agreement entered into pursuant to section 3
of P.L.2023, c.25 (C.26:2G-41), and to the extent necessary to effectuate such
resolution, which shall be used in accordance with the provisions of
subsections d., e., and f. of this section.</p>

<p class=MsoNormal style='line-height:150%'>     (4) Moneys from the fund may
be transferred to other State departments as directed by the Commissioner of
Human Services in support of the purposes provided for in this act, subject to
the approval of the Director of Budget and Accounting.</p>

<p class=MsoNormal style='line-height:150%'>     d.    Notwithstanding section
2 of P.L.1999, c.129 (C.56:8-14.3), section 15 of P.L.2003, c.76 (C.56:8-133),
and the &quot;New Jersey False Claims Act,&quot; P.L.2007, c.265 (C.2A:32C-1 et
seq.), the department shall direct the allocation and disbursement of moneys in
the Opioid Recovery and Remediation Fund established by this section, and shall
do so in consultation with the Opioid Recovery and Remediation Advisory
Council, established pursuant to section 2 of this act.  The department shall
allocate funds with an emphasis on supporting programs and strategies that are
evidence-based or evidence-informed and, in making such allocations, shall
consider equitable access for underserviced communities Statewide.</p>

<p class=MsoNormal style='line-height:150%'>     e.     Moneys, other than
attorneys' fees, costs, and expenses related to litigation, that are allocated
to or otherwise received by the State or any county or municipality as a result
of a national opioid litigation resolution, shall be dedicated and used, consistent
with the terms of an applicable national opioid litigation resolution and any
applicable agreement entered into pursuant to section 3 of P.L.2023, c.25
(C.26:2G-41), for the purpose of addressing opioid use disorder and any
co-occurring substance use disorder or mental health conditions through
evidence-based or evidence-informed practices or strategies that may include,
but shall not be limited to, the following:</p>

<p class=MsoNormal style='line-height:150%'>     (1) Supporting the treatment
of opioid use disorders and any co-occurring substance use disorder or mental
health conditions through evidence-based or evidence-informed programs or
strategies;</p>

<p class=MsoNormal style='line-height:150%'>     (2) Supporting individuals in
recovery from opioid use disorder, as well as any co-occurring substance use
disorder or mental health conditions, through evidence-based or
evidence-informed programs or strategies, including, but not limited to,
providing support services to the families of such individuals;</p>

<p class=MsoNormal style='line-height:150%'>     (3) Providing connections to
care for people who have, or are at risk of developing, an opioid use disorder
or a co-occurring substance use disorder or mental health condition, through
evidence-based or evidence-informed programs or strategies;</p>

<p class=MsoNormal style='line-height:150%'>     (4) Using evidence-based or
evidence-informed programs or strategies to address the needs of persons with
an opioid use disorder or a co-occurring substance use disorder or mental
health condition who are involved in, are at risk of becoming involved in, or
are transitioning out of, the criminal justice system;</p>

<p class=MsoNormal style='line-height:150%'>     (5) Using evidence-based or
evidence-informed programs or strategies to address the needs of pregnant or
parenting persons with opioid use disorder or a co-occurring substance use
disorder or mental health condition, and the needs of the families of such
individuals, including babies with neonatal abstinence syndrome;</p>

<p class=MsoNormal style='line-height:150%'>     (6) Supporting efforts to
prevent over-prescribing and ensure appropriate prescribing and dispensing of
opioids through evidence-based or evidence-informed programs or strategies;</p>

<p class=MsoNormal style='line-height:150%'>     (7) Using evidence-based or
evidence-informed programs or strategies to support efforts to discourage or
prevent the misuse of, and the development of substance use disorders
involving, opioids;</p>

<p class=MsoNormal style='line-height:150%'>     (8) Using evidence-based or
evidence-informed programs or strategies to support efforts to prevent or
reduce overdose deaths or other opioid-related harms;</p>

<p class=MsoNormal style='line-height:150%'>     (9) Educating law enforcement
or other first responders regarding appropriate practices and precautions when
dealing with fentanyl and other drugs;</p>

<p class=MsoNormal style='line-height:150%'>     (10) Providing wellness and
support services for first responders and others who experience secondary
trauma associated with opioid-related emergency events;</p>

<p class=MsoNormal style='line-height:150%'>     (11) Supporting efforts to
provide leadership, planning, coordination, facilitations, training, and
technical assistance to abate the opioid epidemic through activities, programs,
and strategies;</p>

<p class=MsoNormal style='line-height:150%'>     (12) Supporting training to
abate the opioid epidemic through activities, programs, or strategies;</p>

<p class=MsoNormal style='line-height:150%'>     (13) Supporting opioid
abatement research;</p>

<p class=MsoNormal style='line-height:150%'>     (14) Supporting such other
strategies as may be expressly identified in any national opioid litigation
resolution; <b><span style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>and<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b></p>

<p class=MsoNormal style='line-height:150%'>     (15) Administrative expenses,
subject to limits imposed by any national opioid litigation resolution or by
any agreement entered pursuant to section 3 of P.L.2023, c.25 (C.26:2G-41)<u>;
and</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(16) Supporting case management
and recovery support services provided through the Support Team Addiction
Recovery (STAR) and the Support Team Addiction Recovery (STAR) Jail Expansion programs
pursuant to section 2 of P.L.    , c.   (C.             ) (pending before the
Legislature as this bill)</u>.</p>

<p class=MsoNormal style='line-height:150%'>     f.     Moneys, other than
attorneys' fees, costs, and expenses related to litigation, that are allocated
to or otherwise received by the State or any of its counties or municipalities
as a result of a national opioid litigation resolution shall be used to
supplement, and shall not supplant, federal, State, county, or municipal funds,
as the case may be, that otherwise would have been used to carry out the
purposes delineated in this act, and no amount of such moneys shall be used to
reimburse the State or any of its counties or municipalities for past
expenditures, except as may otherwise be required to refund to the federal
government a portion of the moneys.</p>

<p class=MsoNormal style='line-height:150%'>     g.    For the purposes of
P.L.2023, c.25 (C.26:2G-39 et seq.), &quot;national opioid litigation
resolution&quot; means a settlement agreement, entered into by the Attorney
General of New Jersey on behalf of the State and by other state attorneys
general on behalf of their respective states, which provides for the
participation of states, counties, and municipalities to resolve claims by the
State attorneys general and counties and municipalities against opioid
manufacturers, opioid distributors, or pharmacies, or persons or entities
affiliated with an opioid manufacturer, opioid distributor, or pharmacy,
related to the manufacture, marketing, distribution, or dispensing of opioids,
or a bankruptcy plan which is governed by an agreement entered into pursuant to
section 3 of P.L.2023, c.25 (C.26:2G-41) and which has received final approval
and that channels, releases, or otherwise finally disposes of such claims
including those of the State and its counties and municipalities.</p>

<p class=MsoNormal style='line-height:150%'>(cf: P.L.2023, c.25, s.1)</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     2.  (New section)  a.  There
is allocated from the Opioid Recovery and Remediation Fund, established
pursuant to section 1 of P.L.2023, c.25 (C.26:2G-39), to the Department of
Human Services $1,995,000 to supplement the federal funds appropriated to
counties for the Support Team Addiction Recovery (STAR) and the Support Team
Addiction Recovery (STAR) Jail Expansion programs administered by the Division
of Mental Health and Addiction Services as follows:</p>

<p class=MsoNormal style='line-height:150%'>     (1) $1,715,000 to supplement
existing federal grant monies appropriated to counties for STAR programs;</p>

<p class=MsoNormal style='line-height:150%'>     (2) $192,500 to establish a
STAR Jail Expansion program in Passaic county; and</p>

<p class=MsoNormal style='line-height:150%'>     (3)  $87,500 to provide for:</p>

<p class=MsoNormal style='line-height:150%'>     (a) staff salaries and assumed
salary increases for case managers and recovery support specialists hired by
the STAR Jail Expansion program established in Passaic county; and </p>

<p class=MsoNormal style='line-height:150%'>     (b) salary increases for case
managers and recovery support specialists hired by the STAR Jail Expansion
program in Atlantic, Bergen, Camden, Essex, Gloucester, Hudson, Mercer,
Middlesex, Monmouth, and Ocean counties.</p>

<p class=MsoNormal style='line-height:150%'>     b.  Nothing in this section
shall imply or require that the funds allocated from the Opioid Recovery and
Remediation Fund pursuant to P.L.    , c.    (C.         ) (pending before the
Legislature as this bill) replace or decrease the amount of existing federal
grant monies appropriated to counties for STAR and STAR Jail Expansion programs.</p>

<p class=MsoNormal style='line-height:150%'>     c.  As used in this section:</p>

<p class=MsoNormal style='line-height:150%'>     Support Team Addiction
Recovery (STAR) program means a program administered by the Division of Mental
Health and Addiction Services in the Department of Human Services which provides
case management and recovery support services to individuals with a substance
use disorder.</p>

<p class=MsoNormal style='line-height:150%'>     Support Team Addiction
Recovery (STAR) Jail Expansion program means a STAR program which specifically
provides case management and recovery support services to individuals with
substance use disorders who were recently released from a State, county, or
local correctional facility.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     3.  (New section)  The
Commissioner of Human Services, pursuant to the Administrative Procedure Act
P.L.1968, c.410 (C.52:14B-1 et seq.), shall adopt such rules and regulations as
necessary to implement the provisions of this act. </p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     4.  This act shall take effect
immediately, except that the Commissioner of Human Services may take any
anticipatory administrative action in advance as shall be necessary for the
implementation of this act.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'>STATEMENT</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     This bill amends section 1 of
P.L.2023, c.25 (C.26:2G-39) to allow moneys received by the State as a result
of the national opioid litigation resolution and deposited into the Opioid
Recovery and Remediation Fund to be used to support case management and
recovery support services provided through the Support Team Addiction Recovery
(STAR) and the Support Team Addiction Recovery (STAR) Jail Expansion programs.</p>

<p class=MsoNormal style='line-height:150%'>     A STAR program, administered
by the Division of Mental Health and Addiction Services in the Department of
Human Services (DHS), provides case management and recovery support services to
individuals with a substance use disorder.  A STAR Jail Expansion program
specifically provides case management and recovery support services to
individuals with substance use disorders who were recently released from a
State, county, or local correctional facility.</p>

<p class=MsoNormal style='line-height:150%'>     The bill allocates $1,995,000
from the Opioid Recovery and Remediation Fund to the DHS to supplement the
federal funds appropriated to counties for STAR and STAR Jail expansion
programs as follows:  (1) $1,715,000 to supplement existing federal grant
monies appropriated to counties for STAR programs; (2) $192,500 to establish a
STAR Jail Expansion program in Passaic county; and (3) $87,500 to provide for
salaries and assumed salary increases for case managers and recovery support
specialists hired by STAR and STAR Jail expansion programs.<br clear=all
style='page-break-before:always'>
</p>

<p class=MsoNormal style='line-height:150%'>     The bill also stipulates the
funds allocated from the Opioid Recovery and Remediation Fund are not to replace
or decrease the amount of existing federal grant monies appropriated to
counties for the STAR and STAR Jail Expansion programs.</p>

</div>

</body>

</html>
